Capital Research Global Investors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $731M | Sell |
|
|||||
|
2022
Q4 | $1.05B | Sell |
|
|||||
|
2022
Q3 | $946M | Buy |
|
|||||
|
2022
Q2 | $701M | Sell |
|
|||||
|
2022
Q1 | $1.24B | Sell |
|
|||||
|
2021
Q4 | $1.06B | Buy |
|
|||||
|
2021
Q3 | $1.16B | Sell |
|
|||||
|
2021
Q2 | $1.21B | Sell |
|
|||||
|
2021
Q1 | $1.49B | Sell |
|
|||||
|
2020
Q4 | $1.26B | Buy |
|
|||||
|
2020
Q3 | $1.17B | Sell |
|
|||||
|
2020
Q2 | $1.6B | Buy |
|
|||||
|
2020
Q1 | $1.17B | Sell |
|
|||||
|
2019
Q4 | $1.28B | Buy |
|
|||||
|
2019
Q3 | $901M | Buy |
|
|||||
|
2019
Q2 | $1.21B | Buy |
|
|||||
|
2019
Q1 | $2.01B | Buy |
|
|||||
|
2018
Q4 | $1.88B | Buy |
|
|||||
|
2018
Q3 | $2.56B | Sell |
|
|||||
|
2018
Q2 | $2.97B | Buy |
|
|||||
|
2018
Q1 | $2.08B | Buy |
|
|||||
|
2017
Q4 | $1.87B | Buy |
|
|||||
|
2017
Q3 | $1.23B | Sell |
|
|||||
|
2017
Q2 | $2.54B | Buy |
|
|||||
|
2017
Q1 | $2.15B | Buy |
|
|||||
|
2016
Q4 | $1.61B | Buy |
|
|||||
|
2016
Q3 | $960M | Buy |
|
|||||
|
2016
Q2 | $867M | Buy |
|
|||||
|
2016
Q1 | $618M | Buy |
|
|||||
|
2015
Q4 | $747M | Buy |
|
|||||
|
2015
Q3 | $210M | Hold |
|
|||||
|
2015
Q2 | $219M | Sell |
|
|||||
|
2015
Q1 | $575M | Sell |
|
|||||
|
2014
Q4 | $1.43B | Sell |
|
|||||
|
2014
Q3 | $1.68B | Sell |
|
|||||
|
2014
Q2 | $1.72B | Sell |
|
|||||
|
2014
Q1 | $2.29B | Sell |
|
|||||
|
2013
Q4 | $1.94B | Sell |
|
|||||
|
2013
Q3 | $2.23B | Buy |
|
|||||
|
2013
Q2 | $2.28B | Buy |
|